NeuBase Therapeutics (NASDAQ:NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.
https://seekingalpha.com/news/4013366-symetryx-exits-stake-in-neubase-therapeutics-shares-fall
NeuBase Therapeutics (NASDAQ:NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.
https://seekingalpha.com/news/4013366-symetryx-exits-stake-in-neubase-therapeutics-shares-fall
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.